Skip to main content
CAPR
NASDAQ Life Sciences

Capricor Slides 10% as OLE Data Fails to Sway FDA Skeptics

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$8.22
Mkt Cap
$477.902M
52W Low
$2.96
52W High
$40.37
52W Position info
178% above low
Off High info
80% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

CAPR has more than doubled off its 52-week low of $2.96 on light trading volume (0.3× avg).

Summary

Capricor shares fell ~10% Monday despite positive 24-month open-label extension data for deramiocel in Duchenne muscular dystrophy. The HOPE-3 crossover analysis showed a 76% slowing of upper limb decline in patients who switched from placebo, but investors remain focused on the FDA's earlier concerns about the randomized portion of the trial. H.C. Wainwright's Joseph Pantginis expects a Complete Response Letter, while Cantor Fitzgerald's Kristen Kluska sees a favorable risk/reward leaning toward approval. The data was included in a major BLA amendment, with the PDUFA date set for November 22, 2026. This follows the FDA advisory committee's 9-3 vote against effectiveness in late July and the agency's decision to review the new 24-month data in August.

At the time of this announcement, CAPR was trading at $8.22 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $477.9M. The 52-week trading range was $2.96 to $40.37. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

CAPR - Latest Insights

CAPR
Nov 18, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $8.77
Real-time Price: $7.93 info
Change: -$0.837 (-10%) info
Market Cap: $437.81M info
CAPR
Nov 10, 2026, 5:25 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $9.35
Real-time Price: $7.93 info
Change: -$1.42 (-15%) info
Market Cap: $437.81M info
CAPR
Nov 10, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $9.10
Real-time Price: $7.93 info
Change: -$1.17 (-13%) info
Market Cap: $437.81M info
CAPR
Nov 10, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.91
Real-time Price: $7.93 info
Change: -$0.972 (-11%) info
Market Cap: $437.81M info
CAPR
Nov 09, 2026, 9:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $9.08
Real-time Price: $7.93 info
Change: -$1.15 (-13%) info
Market Cap: $437.81M info